Side-by-side comparison of AI visibility scores, market position, and capabilities
Policy management and regulatory change management platform for financial services, London UK. Helps banks track regulatory updates and align internal policies automatically.
Clausematch is a London, United Kingdom-based regulatory technology company founded in 2012 that provides a policy management and regulatory change management platform specifically designed for banks, insurance companies, and other financial services firms operating in complex multi-jurisdictional regulatory environments. The company serves financial institutions seeking to automate the labor-intensive process of monitoring regulatory changes, assessing impact, and updating internal policies and procedures to maintain ongoing compliance.\n\nClausematch's platform ingests regulatory content from global regulatory sources — including the FCA, PRA, ECB, SEC, and other authorities — and uses natural language processing to extract regulatory obligations, map them to internal policies, and identify gaps when regulatory changes occur. When a regulator publishes new rules or guidance, Clausematch automatically identifies which internal policies are affected and routes them to policy owners for review and update. This automation reduces the regulatory change management cycle from weeks of manual analysis to a structured, trackable workflow.\n\nThe company's policy management module provides a structured environment for drafting, reviewing, approving, and publishing policies and procedures, with version control, approval workflows, and staff acknowledgment tracking. Clausematch serves tier-one and tier-two banks across Europe, the United States, and Asia, typically competing for selection alongside manual processes and generic document management tools rather than other dedicated regulatory change management platforms. Competitors include Ascent RegTech and Corlytics in the regulatory intelligence and change management segment.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.